UNSPSC 51312109: Oxomemazine hydrochloride

This classification denotes an antimuscarinic agent C18H22N2O2S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6BOK44G9K6, chemically known as phenothiazine, 10-(3-(dimethylamino)-2-methylpropyl)-, 5,5-dioxide, monohydrochloride, but more generally known as oxomemazine hydrochloride, which bears US NIH Compound Identifier 3083870. European Medicines Agency schedules Oxomemazine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21934.

Most nations, for tariff and trade purposes, schedule oxomemazine hydrochloride under HS 29343090 and SITC 51578. As of Q4 2014, OXOMEMAZINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC(CN1C2CCCCC2S(=O)(=O)C3C1CCCC3)CN(C)C.CL.

UNSPSC 51312109 Oxomemazine hydrochloride is a Commodity code that in recent state and local procurement activity reflects sourcing of pharmaceutical and medical countermeasure products, though the single recent opportunity on file diverges significantly from the code's nominal scope. Seminole County, Florida posted IFB60459723LAS in June 2026 seeking procurement of naloxone and drug deactivation systems rather than oxomemazine hydrochloride specifically, indicating either a tagging mismatch or a broader interpretation of pharmaceutical countermeasures within the county's procurement taxonomy. The work involves sourcing finished pharmaceutical products and related medical systems for community health support, with vendors responsible for delivery logistics and compliance with drug-free workplace certification, E-Verify requirements, and federal regulations tied to potential FEMA funding. Issuing bodies under this code appear to include county health departments and community health agencies focused on opioid response and harm-reduction initiatives.

Seminole County, Florida represents the only recent opportunity identified under this code as of mid-2026. The IFB called for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the bid deadline was July 26, 2023, with an initial two-year contract term and one-year renewal option, fixed-fee pricing, and a three-month probationary period allowing termination without cause. The absence of additional recent opportunities in the block suggests minimal current state and local procurement activity specifically under this commodity code, though the mismatch between the code's nominal scope (oxomemazine hydrochloride) and the actual solicitation content (naloxone and drug deactivation systems) signals that relevant pharmaceutical and medical countermeasure procurement may be tagged under different UNSPSC codes in other jurisdictions.